BOSTON, May 9 /PRNewswire/ -- Scientists and senior level management executives will gather to exchange the latest drug discovery and development techniques at the 8th Annual Anti-Cancer Drug Discovery & Development Summit on July 17-18, 2006 at the Hilton Boston Back Bay Hotel in Boston, MA.
Robert A. Weinberg, Ph.D., winner of the 2006 Landon-AACR Prizes for Basic and Translational Cancer Research, will present the opening keynote address titled “Mechanisms of Malignant Progression” and Jeffrey H. Hanke, Ph.D., Vice President, Cancer Research, AstraZeneca will present the industry keynote on “Inhibition of Tumor Angiogenesis by Targeting VEGF Receptor Function, Preclinical and Emerging Clinical Data.”
This summit has been highly proclaimed as the premier information networking meeting in this space, this year’s meeting will bring together the finest group of oncology experts from around the world to address the most promising avenues of investigation, according to the Strategic Research Institute.
This agenda offers the hottest and latest anti-cancer research on: 1) Targeted Therapeutics, 2) Antibody Derived Targets & Biologics, and 3) Angiogenesis.
Highlighted research programs include the following: * Targeting VEGF Pathway with mAb’s and Small Molecules * EGF Pathway Inhibitors (Erlotinib and Cetuximab) * Emerging Approaches to Target the c-Met/ HGF Axis * Selective and Multi-Targeted Kinase Inhibitors * Novel Biologicals (CD20, CTLA4, Angiopoietins, PSCA, SDF and Eph) * Emerging Data on Inhibitors of Mek, Hedgehog, CDK and HDAC
Complete list of participating companies and institutions includes: Agensys, Amgen, Arqule, Array Biopharma, Astrazeneca, Chemokine Therapeutics, Compound Therapeutics, Curagen, Curis, Dana-Farber Cancer Institute, Exelixis, Genentech, Genmab A/S, Harvard University, Hoffmann-La Roche, Immunogen, Ludwig Center for Cancer Research, MD Anderson Cancer Center, Medarex, Medimmune, MIT, OSI Pharmaceuticals, Pfizer, Sunesis, Sherris Pharma Partners, University of Texas and Whitehead Institute.
To receive the full agenda in PDF, register, or information on becoming a media partner, please contact: Amy Yueh of Strategic Research Institute at ayueh@srinstitute.com or 212-967-0095, x258. The conference website is at www.srinstitute.com/cancer.
For more information on sponsorship/exhibition opportunities, please contact: Sandra Shlayanat sshlayan@srinstitute.com or 212.967.0095, extension 239.
Strategic Research Institute http://www.srinstitute.com
Strategic Research Institute
CONTACT: Media, Amy Yueh, ayueh@srinstitute.com, +1-212-967-0095, ext.258, or Sponsorship/Exhibition, Sandra Shlayanat, sshlayan@srinstitute.com,+1-212-967-0095, ext. 239, both of Strategic Research Institute
